利奈唑胺治疗耐药结核病的临床疗效和安全性评估OACSTPCD
Evaluation of Clinical Efficacy and Safety of Linezolid in the Treatment of Drug Resistant Tuberculosis
目的 评价利奈唑胺(Linezolid,Lzd)治疗耐药结核病(DR-TB)的临床疗效和安全性.方法 收集2014年5月至2016年5月我院10例采用含利奈唑胺为主的化疗方案治疗的耐药肺结核患者诊治资料,分析其临床疗效及用药安全性.结果 10例患者临床症状症状均有不同程度改善.8例患者治疗后复查胸CT肺部病灶有吸收好转,空洞缩小,其中4例患者空洞闭合(最短时间2个月,最长时间9个月).6例痰涂片阳性患者中有4例患者痰抗酸染色涂片阴转,阴转时间为3…查看全部>>
Objective To evaluate the efficacy and safety of linezolid(Lzd)in the treatment of drug-resistant tuberculosis (DR-TB).Methods From May 2014 to May 2016,10 cases of drug-resistant pulmonary tuberculosis patients treated with lin-ezolid in our hospital were collected and analyzed.The clinical efficacy and safety of the drug use were analyzed.Results The clinical symptoms and symptoms of 10 cases were improved in different degrees.Chest CT was reviewed in 8 pa…查看全部>>
杨铭;梁宗安;袁平;陈黎;李曦;岳冀
四川大学华西医院,四川成都610041成都市公共卫生临床医疗中心结核科,四川成都610016四川大学华西医院,四川成都610041成都市公共卫生临床医疗中心结核科,四川成都610016成都市公共卫生临床医疗中心结核科,四川成都610016成都市公共卫生临床医疗中心结核科,四川成都610016
医药卫生
耐药结核病利奈唑胺有效性安全性不良反应
drug resistant tuberculosislinezolidefficacysafetyadverse effects
《四川医学》 2017 (11)
1229-1233,5
成都市科技局科研项目(编号:2013-HM01-00177-SF)
评论